Microglial innate memory and epigenetic reprogramming in neurological disorders.

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are the primary immune cells in the central nervous system (CNS).
• Their dysregulation is implicated in CNS pathologies.
• Epigenetic modifications influence microglial responses.

Purpose of the Study:

• To explore epigenetic mechanisms in microglial activation.
• To discuss the role of microglial priming in neurological diseases.
• To highlight clinical implications and therapeutic potential.

Main Methods:

• Review of existing literature on microglial epigenetics and innate immune memory.
• Analysis of evidence linking epigenetic dysregulation to CNS pathologies.
• Discussion of microglial priming phenomena.

Main Results:

• Microglia exhibit phenotypic plasticity and are crucial for brain homeostasis.
• Aberrant microglial activation and epigenetic dysregulation are linked to CNS diseases.
• Microglial priming, a form of innate immune memory, enhances responses to inflammatory stimuli.

Conclusions:

• Epigenetic reprogramming drives microglial priming in neurological conditions.
• This priming contributes to disease pathogenesis.
• Targeting epigenetic modifications presents novel therapeutic strategies for CNS disorders.